{"DataElement":{"publicId":"7601835","version":"1","preferredName":"Epithelial Cell Adhesion Molecule Protein Expression BerEP4 IHC Staining Method Result","preferredDefinition":"Text term that represents the status of the epithelial cell adhesion Molecule (EPCAM) protein expression using BerEP4 immunohistochemistry.","longName":"7595780v1.0:6061805v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"7595780","version":"1","preferredName":"Epithelial Cell Adhesion Molecule Protein Expression BerEp4 IHC Staining Method Performed","preferredDefinition":"Epithelial cell adhesion molecule (314 aa, ~35 kDa) is encoded by the human EPCAM gene. This protein is involved in both cell adhesion and cellular proliferation._The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus._An immunohistochemical technique utilizing the mouse monoclonal IgG1 antibody BerEp4, which is directed against epithelial cell adhesion molecule (EPCAM). BerEp4 specifically binds to EPCAM, a protein that is selectively expressed in most normal epithelium but not expressed in squamous epithelium and mesothelium. This staining method is used to identify certain cancers and may be used to distinguish neoplasms derived from squamous epithelium and mesothelium from other epithelial-derived neoplasms._Executed and carried through to completion.","longName":"7595777v1.0:7595778v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"7595777","version":"1","preferredName":"Epithelial Cell Adhesion Molecule","preferredDefinition":"Epithelial cell adhesion molecule (314 aa, ~35 kDa) is encoded by the human EPCAM gene. This protein is involved in both cell adhesion and cellular proliferation.","longName":"C20209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial Cell Adhesion Molecule","conceptCode":"C20209","definition":"Epithelial cell adhesion molecule (314 aa, ~35 kDa) is encoded by the human EPCAM gene. This protein is involved in both cell adhesion and cellular proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD94A4CF-56A6-6092-E053-4EBD850A4D19","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7595778","version":"1","preferredName":"Protein Expression BerEp4 IHC Staining Method Performed","preferredDefinition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.:An immunohistochemical technique utilizing the mouse monoclonal IgG1 antibody BerEp4, which is directed against epithelial cell adhesion molecule (EPCAM). BerEp4 specifically binds to EPCAM, a protein that is selectively expressed in most normal epithelium but not expressed in squamous epithelium and mesothelium. This staining method is used to identify certain cancers and may be used to distinguish neoplasms derived from squamous epithelium and mesothelium from other epithelial-derived neoplasms.:Executed and carried through to completion.","longName":"C18966:C178239:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"BerEp4 IHC Staining Method","conceptCode":"C178239","definition":"An immunohistochemical technique utilizing the mouse monoclonal IgG1 antibody BerEp4, which is directed against epithelial cell adhesion molecule (EPCAM). BerEp4 specifically binds to EPCAM, a protein that is selectively expressed in most normal epithelium but not expressed in squamous epithelium and mesothelium. This staining method is used to identify certain cancers and may be used to distinguish neoplasms derived from squamous epithelium and mesothelium from other epithelial-derived neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD94A4CF-56B8-6092-E053-4EBD850A4D19","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD94A4CF-56C9-6092-E053-4EBD850A4D19","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2.25.2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6061805","version":"1","preferredName":"Protein Expression IHC Result","preferredDefinition":"The result of an action.","longName":"6061805v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Equivocal","valueDescription":"Equivocal","ValueMeaning":{"publicId":"5178198","version":"1","preferredName":"Equivocal","longName":"5178198","preferredDefinition":"Open to question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Equivocal","conceptCode":"C86071","definition":"Open to question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E58EB10-C86C-1000-E050-BB89AD43077B","latestVersionIndicator":"Yes","beginDate":"2016-03-18","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-18","modifiedBy":"COOPERM","dateModified":"2018-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33A4-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2840098","version":"1","preferredName":"Negative Finding","longName":"2840098","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635F3981-C786-F359-E040-BB89AD435EC5","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33AF-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"5042698","version":"1","preferredName":"Positive Finding","longName":"5042698","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BCDB4E-8EE7-8E8D-E050-BB89AD432DF3","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-11-04","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AA7615-33BA-3AB1-E053-F662850A7528","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"Cannot be determined","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DF04E-3926-03A7-E053-F662850AA4EC","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"Abnormal null expression (complete loss of expression)","valueDescription":"Complete Loss Protein Expression","ValueMeaning":{"publicId":"6689301","version":"1","preferredName":"Complete Loss Protein Expression","longName":"6689301","preferredDefinition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: A gradual decline in amount or activity.: The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86200CA4-B54B-5487-E053-F662850A8E34","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86200CA4-B564-5487-E053-F662850A8E34","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Abnormal strong diffuse overexpression (>90%)","valueDescription":"Abnormal Strong Diffuse Protein Overexpression","ValueMeaning":{"publicId":"6689302","version":"1","preferredName":"Abnormal Strong Diffuse Protein Overexpression","longName":"6689302","preferredDefinition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: Having strength, power, or intensity greater than average or expected.: Widely spread; not localized or confined.: In biology, to make too many copies of a protein or other substance. Overexpression of certain proteins or other substances may play a role in cancer development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Strong","conceptCode":"C62223","definition":"Having strength, power, or intensity greater than average or expected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Overexpression","conceptCode":"C18211","definition":"Synthesis of excess polypeptide within the cell. Overexpression is often due to the amplification or deregulation of the gene which encodes the gene product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86200CA4-B573-5487-E053-F662850A8E34","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86200CA4-B58C-5487-E053-F662850A8E34","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal Protein Expression","ValueMeaning":{"publicId":"6689303","version":"1","preferredName":"Normal Protein Expression","longName":"6689303","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86200CA4-B599-5487-E053-F662850A8E34","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86200CA4-B5B2-5487-E053-F662850A8E34","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"4163021","version":"1","preferredName":"Not Done","longName":"4163021","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2B5E544-9A39-F7D4-E040-BB89AD4312F7","latestVersionIndicator":"Yes","beginDate":"2014-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-18","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"98C0E5EC-34C4-7FC4-E053-F662850A326C","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","deletedIndicator":"No"},{"value":"Present","valueDescription":null,"ValueMeaning":{"publicId":"2562862","version":"1","preferredName":"Present","longName":"2562862","preferredDefinition":"Being or existing in a specified place or at the specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C29B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2018-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E83187EB-E56C-5FAF-E053-731AD00AFB04","beginDate":"2022-09-08","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-09-08","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","deletedIndicator":"No"},{"value":"Absent","valueDescription":null,"ValueMeaning":{"publicId":"2562943","version":"1","preferredName":"Absent","longName":"2562943","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C2EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"REEVESD","dateModified":"2014-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E83187EB-E56D-5FAF-E053-731AD00AFB04","beginDate":"2022-09-08","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-09-08","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648DF04E-390E-03A7-E053-F662850AA4EC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"RAGUNATHANU","dateModified":"2022-09-08","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"7589447","version":"1","longName":"Mesothelioma","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"BerEP4 expression by IHC","type":"Preferred Question Text","description":"BerEP4 expression by IHC","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDAA3342-6CBD-1C09-E053-4EBD850A350D","latestVersionIndicator":"Yes","beginDate":"2021-03-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-16","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}